Arterys Completes Series B to accelerate product commercialization
November, 15 2017
SAN FRANCISCO, Nov. 15, 2017 /PRNewswire/ — Arterys Inc., a privately-held company leading the transition to cloud infrastructure and artificial intelligence in medical imaging, today announced the close of its $30M Series B financing round. The investment was led by Temasek, with strategic investors Northwell Health Ventures, NewYork-Presbyterian, Varian Medical Systems and GE Ventures, and joined by Fosun, DNA Capital, Emergent Medical Partners, and ORI Capital. Arterys plans to use the funding to expand its web-based artificial intelligence platform, and launch several products in oncology and neurology, and to accelerate the commercialization of its cardiac offering. This new round will enable more radiologists to benefit from artificial intelligence in their daily work.
Fabien Beckers, PhD, founder and CEO of Arterys, commented: “This financing includes pioneers in healthcare who recognize the game-changing value of a cloud AI platform to unlock the potential of radiology data to improve patient care. We are excited to grow our offerings and work with our clinical partners in building powerful, accessible tools for the medical imaging community to accelerate the transition to data driven medicine.”
Arterys has created a novel AI platform for medical image analytics. Contrary to the current solutions that are installed inside hospitals, Arterys software is web based. As a result, physicians benefit from vast amounts of computation, which is necessary to run artificial intelligence algorithms in a timely manner. Physicians can now process their patient cases with support from AI algorithms that are embedded in their workflow. This is possible thanks to proprietary technology that protects patient information and complies with data privacy regulations in the U.S. and EU.
